37
Pharma & HealthcareAvoid
Baroda BNP Paribas Health And Wellness
Baroda BNP Paribas · Direct–Growth · rank #14 of 18 by Smart Score
Data updated
Trailing returns
1 Year
12.4%
+9.3% vs index
3 Years
—
5 Years
—
Since launch
8.1%
Year-by-year performance
2026
+14.9%+17.0% vs index
Why this score
Baroda BNP Paribas Health And Wellness scores 37/100 — #14 of 18 Pharma & Healthcare fund (Avoid). It stands out for volatility — beating 97% of peers on volatility. The main drag is its sharpe ratio (better than only 3% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio0.14 · 3rd percentile in category
Volatility11.42 · 97th percentile in category
Sortino ratio0.20 · 3rd percentile in category
1Y return12.37% · 15th percentile in category
Fund size519.48 Cr · 36th percentile in category
Expense ratio1.04% · 47th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd8.82%
2.Torrent Pharmaceuticals Ltd8.58%
3.Divi's Laboratories Ltd6.66%
4.Lupin Ltd6.46%
5.Ipca Laboratories Ltd5.72%
30 disclosed equity positions · portfolio as of Jul 2026 · weights are % of total corpus.